Cargando…
Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review
Cystic fibrosis (CF) is a genetic disease that causes absence or dysfunction of a protein named transmembrane conductance regulatory protein (CFTR) that works as an anion channel. As a result, the secretions of the organs where CFTR is expressed are very viscous, so their functionality is altered. T...
Autores principales: | Girón Moreno, Rosa María, García-Clemente, Marta, Diab-Cáceres, Layla, Martínez-Vergara, Adrián, Martínez-García, Miguel Ángel, Gómez-Punter, Rosa Mar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144952/ https://www.ncbi.nlm.nih.gov/pubmed/33922413 http://dx.doi.org/10.3390/antibiotics10050486 |
Ejemplares similares
-
Longitudinal Study of Therapeutic Adherence in a Cystic Fibrosis Unit: Identifying Potential Factors Associated with Medication Possession Ratio
por: Girón, Rosa Mª, et al.
Publicado: (2022) -
Role of C-reactive protein as a biomarker for prediction of the severity of pulmonary exacerbations in patients with cystic fibrosis
por: Girón-Moreno, Rosa Maria, et al.
Publicado: (2014) -
Long-term safety and efficacy of tobramycin in the management of cystic fibrosis
por: Vázquez-Espinosa, Emma, et al.
Publicado: (2015) -
Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity
por: Wang, Xuejie, et al.
Publicado: (2021) -
Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry
por: De la Rosa, David, et al.
Publicado: (2017)